START FREE TRIAL

Intel AI Chip Boom 2026 Could Make It Apple’s Next Chip Supplier!

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

Intel (NASDAQ:INTC) shares surged this week after a bullish upgrade that reignited investor hopes in the chipmaker. KeyBanc boosted Intel to “Overweight,” pointing to AI infrastructure as a powerful near-term growth engine. With its server CPUs nearly sold out for the year, Intel is reportedly considering a 10–15% increase in average selling prices (ASPs). At the same time, progress in its 18A manufacturing node has analysts warming to Intel’s foundry ambitions. The company might even land Apple as a customer for low-end Mac and iPad chips starting in 2027—a move that would put it squarely in contention as a top-two global chip manufacturer. Still, it’s not all smooth sailing. Execution risks and stiff competition from AMD and TSMC loom large. And at current levels, the rally assumes a lot has already gone right. The question is: can Intel really deliver?

Server CPU Demand Is On Fire

Intel’s server CPU business is having a moment—and that moment might just stretch through 2026. Thanks to surging demand for AI infrastructure, Intel’s data center chips are reportedly…

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Oracle’s Earnings “Disaster” Is the BEST NEWS For The AI Infrastructure Trade!

Oracle reported after the bell last night. Here are...

Oracle Reports Tonight. The Revenue Number Is Not The Question.

Tonight at 5 PM ET, Oracle drops its fiscal...

Amazon Just Paid BILLIONS For Glass. The AI Bottleneck NOBODY Is Talking About!

On Monday, Amazon announced a multiyear, multibillion-dollar agreement with...

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Ingredion (NYSE:INGR) has moved into deal mode with a...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal...

Related Articles

Amazon Just Paid BILLIONS For Glass. The AI Bottleneck NOBODY Is Talking About!

On Monday, Amazon announced a multiyear, multibillion-dollar agreement with...

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Ingredion (NYSE:INGR) has moved into deal mode with a...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal...

Broadcom Said 3 Words That Killed The Narrative: “WE ARE CHIPS ONLY!”A

Let's do the math quickly. Broadcom (NASDAQ:AVGO) just reported $10.8...
spot_img

Related Articles

Popular Categories

spot_imgspot_img